In a study, hyperglycemia control (for blood glucose level 80 - 140 mg/dl) using once-daily glargine insulin versus twice-daily NPH/regular insulin in patients after cardiovascular surgery was evaluated. This evidence concerns the gene INS and Hyperglycemia.